These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 6832095

  • 1. Modifying factors in urinary bladder carcinogenesis.
    Ito N, Fukushima S, Shirai T, Nakanishi K, Hasegawa R, Imaida K.
    Environ Health Perspect; 1983 Mar; 49():217-22. PubMed ID: 6832095
    [Abstract] [Full Text] [Related]

  • 2. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
    Ito N, Fukushima S, Shirai T, Nakanishi K.
    Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Fukushima S, Shibata M, Shirai T, Ogiso T, Ito N.
    Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
    [Abstract] [Full Text] [Related]

  • 6. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N.
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S, Mutou T, Takahashi H, Ikegami M, Wanibuchi H, Fukushima S.
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y, Konishi N, Shimoyama T, Hiasa Y.
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [Abstract] [Full Text] [Related]

  • 10. Effects of sex hormones on oncogenesis in rat urinary bladder by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Tanahashi NK, Suzawa N, Azuma C.
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):101-5. PubMed ID: 844928
    [Abstract] [Full Text] [Related]

  • 11. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E, Anjo T, Aoki J, Okada M.
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [Abstract] [Full Text] [Related]

  • 12. Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Hirose M, Ogiso T, Hasegawa R, Arai M, Ito N.
    Gan; 1980 Aug; 71(4):490-500. PubMed ID: 7429086
    [Abstract] [Full Text] [Related]

  • 13. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    McCormick DL, Ronan SS, Becci PJ, Moon RC.
    Carcinogenesis; 1981 Aug; 2(3):251-4. PubMed ID: 7273310
    [Abstract] [Full Text] [Related]

  • 14. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E, Mochizuki M, Okada M.
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [Abstract] [Full Text] [Related]

  • 15. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hirose M, Murasaki G, Imaida K, Fukushima S, Ito N.
    Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G, Miyata Y, Babaya K, Arai M, Fukushima S, Ito N.
    Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
    [Abstract] [Full Text] [Related]

  • 17. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
    Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N.
    Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816
    [Abstract] [Full Text] [Related]

  • 18. Membrane potentials of urinary bladder epithelium in F344 rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium saccharin.
    Imaida K, Oshima M, Fukushima S, Ito N, Hotta K.
    Carcinogenesis; 1983 Mar; 4(6):659-61. PubMed ID: 6861271
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y, Tsuda H, Matayoshi-Miyasato K, Fukushima S, Murasaki G, Ogiso T, Ito N.
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [Abstract] [Full Text] [Related]

  • 20. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
    Nakanowatari J, Fukushima S, Imaida K, Ito N, Nagase S.
    Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.